CTTH
insider transactionsCTT PHARMACEUTICAL HOLDINGS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Repeat buying: An insider buying on several separate days — not just once — is a stronger conviction signal than a single purchase. 1 insider made open-market purchases on 2+ separate days in the last 365 days.
Net shares · 365d
+352.9K
352.9K buy · 0 sell
Net value · 365d
$14.9K
$14.9K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
8
352.9K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for the daily net. Green = net buying, red = net selling.
Transactions · 365d
-
Buy·P
$498
8.3K sh · $0.06
Own +0%
-
Buy·P
$2.5K
62.9K sh · $0.04
Own +1%
-
Buy·P
CTT PHARMACEUTICAL HOLDINGS, INC.
Director
$8.0K
200.0K sh · $0.04
Own +6%
-
Buy·P
$420
7.0K sh · $0.06
Own +0%
-
Buy·P
$409
6.8K sh · $0.06
Own +0%
-
Buy·P
$2.2K
44.1K sh · $0.05
Own +1%
-
Buy·P
$632
15.8K sh · $0.04
Own +0%
-
Grant·A
$30.0K
750.0K sh · $0.04
Own +11%
-
Buy·P
$240
8.0K sh · $0.03
Own +0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Dec 17, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. KEY | Buy P | 8.3K | $498 |
| Nov 20, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. KEY | Buy P | 62.9K | $2.5K |
| Nov 20, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. | Buy P | 200.0K | $8.0K |
| Oct 31, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. KEY | Buy P | 7.0K | $420 |
| Sep 23, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. KEY | Buy P | 6.8K | $409 |
| Aug 2, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. KEY | Buy P | 44.1K | $2.2K |
| Aug 1, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. KEY | Buy P | 15.8K | $632 |
| Aug 1, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. KEY | Grant A | 750.0K | $30.0K |
| Jul 8, 2025 | CTT PHARMACEUTICAL HOLDINGS, INC. KEY | Buy P | 8.0K | $240 |
Buy Sell Non-market (grant · exercise · gift)
About CTTH insider trading
This page tracks insider transactions for CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.